All posts

Follow Us

LinkedInInstagramX
Quarterly ResultsArchiveLast updated 22 November 20262 min read

Ravelcare (RAVEL) Q2 FY27 Profit Doubles, But a One-Off Income Flatters the Result

Ravelcare's Q2 profit surged 97% sequentially, but a large jump in other income accounted for much of the gain, raising questions about core earnings sustainability.

By Vinayak Gandhi, CFA · Created 15 November 2026

Ravelcare's Q2 FY27 profit nearly doubled from the previous quarter, yet a significant portion stemmed from non-operational income. The company's core revenue growth was steady, while institutional investors continued to reduce their stake.

For Ravelcare, a personal care brand betting on new launches, the September quarter delivered a headline profit surge. Yet the numbers reveal a more nuanced story where a one-time income boost played a starring role.

The company's profit after tax nearly doubled to ₹3.84 crore from the March quarter, on a 20.6% sequential rise in revenue to ₹15.15 crore. Year-on-year, profit grew a solid 20% while revenue was up 5.2%.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Revenue & profitQ4 FY25 14.58, Q2 FY26 14.40, Q4 FY26 12.56, Q2 FY27 15.15. Q4 FY25 1.50, Q2 FY26 3.20, Q4 FY26 1.95, Q2 FY27 3.8405101520Q4 '25Q2 '26Q4 '26Q2 '27
  • Revenue (₹ Cr), Q4 FY25: 14.58
  • Revenue (₹ Cr), Q2 FY26: 14.40
  • Revenue (₹ Cr), Q4 FY26: 12.56
  • Revenue (₹ Cr), Q2 FY27: 15.15
  • Profit (₹ Cr), Q4 FY25: 1.50
  • Profit (₹ Cr), Q2 FY26: 3.20
  • Profit (₹ Cr), Q4 FY26: 1.95
  • Profit (₹ Cr), Q2 FY27: 3.84

Revenue (₹ Cr)

Revenue (₹ Cr)Q4 FY25 14.58, Q2 FY26 14.40, Q4 FY26 12.56, Q2 FY27 15.1505101520Q4 '25Q2 '26Q4 '26Q2 '27
  • Revenue (₹ Cr), Q4 FY25: 14.58
  • Revenue (₹ Cr), Q2 FY26: 14.40
  • Revenue (₹ Cr), Q4 FY26: 12.56
  • Revenue (₹ Cr), Q2 FY27: 15.15

Profit (₹ Cr)

Profit (₹ Cr)Q4 FY25 1.50, Q2 FY26 3.20, Q4 FY26 1.95, Q2 FY27 3.8402468Q4 '25Q2 '26Q4 '26Q2 '27
  • Profit (₹ Cr), Q4 FY25: 1.50
  • Profit (₹ Cr), Q2 FY26: 3.20
  • Profit (₹ Cr), Q4 FY26: 1.95
  • Profit (₹ Cr), Q2 FY27: 3.84

Net Profit Margin

Net Profit MarginQ4 FY25 10.3%, Q2 FY26 22.2%, Q4 FY26 15.5%, Q2 FY27 25.3%0%10%20%30%40%Q4 '25Q2 '26Q4 '26Q2 '27
  • Net Profit Margin, Q4 FY25: 10.3%
  • Net Profit Margin, Q2 FY26: 22.2%
  • Net Profit Margin, Q4 FY26: 15.5%
  • Net Profit Margin, Q2 FY27: 25.3%
MetricCurrentQ2 FY27Same quarter LYQ2 FY26
Revenue (₹ Cr)
15.15YoY +5.2%
14.40
Profit (₹ Cr)
3.84YoY +20%
3.20
Net Profit Margin
25.3%YoY +14%
22.2%

The one-off that lifted profit

The quarter's standout figure was other income, which surged to ₹0.72 crore from just ₹0.04 crore in the previous quarter. According to MarketsMojo, this accounted for a significant portion of the profit before tax of ₹5.17 crore. This non-operational gain, not detailed in filings, flattered the bottom-line growth.

Stripping that out, the underlying operating performance still showed improvement. Gross margin expanded 350 basis points year-on-year to 79.9%, notes Alfafinder. The company also cut product returns by 60% and raised average order value by 9% through website upgrades.

Growth bets and institutional skepticism

Management is upbeat, calling it a “solid first half” and betting on new products. A PRO range for marketplaces is live, and a personalised skincare line is slated for a December 2026 launch, with international expansion planned “soon”.

Live Chart

· RAVEL

(BSE)

ISIN: INE0W4D01018

Yet institutional investors have been pulling back. Data from Screener.in shows their combined stake fell from 11.68% in December 2025 to 5.8% by September 2026. This selling suggests some doubt about the sustainability of current margins or the execution of new launches.

Key Points

  • Ravelcare's Q2 profit jumped 97% quarter-on-quarter, but a large, unexplained rise in other income contributed significantly.
  • Underlying operations improved with higher gross margins, lower returns, and a successful PRO category launch on major e-commerce platforms.
  • The company plans a skincare launch by December 2026 to drive future growth, but institutional shareholding has been declining.

Hexa Perspective

Ravelcare's quarter presents a split screen: strong operational discipline against a profit figure boosted by a one-off. The core business is healthier, with better margins and a new distribution channel gaining traction.

The path forward hinges on converting its product pipeline into consistent, high-margin sales without similar income surprises. The declining institutional interest adds a note of caution, making the coming quarters' pure operating performance critical for investor confidence.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Ravelcare (RAVEL) Q2 FY27 results, revenue and profits.

Frequently asked questions

What were Ravelcare's Q2 FY27 results?
Ravelcare reported a revenue of ₹15.15 crore and a net profit of ₹3.84 crore for the quarter ended September 2026. Profit grew 20% year-on-year and nearly doubled (97%) from the previous quarter, though a large increase in other income influenced the sequential jump.
What was Ravelcare's Q2 net profit?
Ravelcare's net profit for the September 2026 quarter (Q2 FY27) was ₹3.84 crore. This marks a 20% increase from the ₹3.20 crore profit in the same quarter last year.
What was Ravelcare's revenue in Q2 FY27?
Ravelcare's revenue from operations in Q2 FY27 (September 2026 quarter) was ₹15.15 crore. This represents a 5.2% increase compared to the ₹14.40 crore revenue in Q2 FY26.
Why did Ravelcare's Q2 profit nearly double sequentially?
Ravelcare's Q2 FY27 profit jumped 97% from the previous quarter partly due to a large increase in other income, which rose to ₹0.72 crore from ₹0.04 crore. This non-operational gain, reported by MarketsMojo, significantly flattered the profit before tax figure.
What is Ravelcare's net profit margin for Q2 FY27?
Ravelcare's net profit margin for Q2 FY27 was 25.3%, a significant improvement from 15.5% in the previous quarter and 22.2% in the same quarter last year. The sequential expansion was heavily influenced by higher other income.
What new products is Ravelcare launching?
According to its investor presentation, Ravelcare plans to launch a personalised skincare range by December 2026. It has also already launched a 'PRO' product category aimed at marketplaces and quick-commerce channels like Amazon and Blinkit.
Are institutional investors buying or selling Ravelcare stock?
Institutional investors have been reducing their stake in Ravelcare. Data from Screener.in shows combined FII and DII holding fell from 11.68% in December 2025 to 8.85% in March 2026, and further to 5.8% by September 2026.
What was Ravelcare's other income in Q2 FY27?
Ravelcare reported other income of ₹0.72 crore in Q2 FY27, a sharp increase from ₹0.05 crore in the year-ago quarter and ₹0.04 crore in the previous quarter. This item significantly boosted the company's profit before tax for the period.
Ravelcare Q2 FY27 results August 2026?
Ravelcare announced its Q2 FY27 (September 2026 quarter) results on November 14, 2026. The company reported revenue of ₹15.15 crore and a net profit of ₹3.84 crore for the period.
Ravelcare H1 FY27 results?
For the first half of FY27 (April-September 2026), Ravelcare reported a standalone revenue of ₹15.15 crore and a profit after tax of ₹3.84 crore. This represents a 20.7% growth in revenue and a 96.6% growth in profit compared to the second half of FY26.